about
cellular response to cocainecellular response to dexamethasone stimuluscellular response to indole-3-methanolcellular response to heparincellular response to mycophenolic acidcellular response to hydrogen peroxidecellular response to nicotinecellular response to ethanolcellular response to nitric oxidecellular response to camptothecincellular response to ATPcellular response to hydroxyureacellular response to cisplatincellular response to caffeinecellular response to dopaminecellular response to folic acidcellular response to progesterone stimuluscellular response to forskolincellular response to muramyl dipeptidecellular response to morphinecellular response to cycloheximidecellular response to menadionecellular response to carbon monoxidecellular response to cortisol stimuluscellular response to genisteincellular response to methotrexatecellular response to rapamycincellular response to benomylcellular response to L-argininecellular response to ozonecellular response to singlet oxygencellular response to nitroglycerincellular response to tacrolimuscellular response to biotincellular response to cobalamincellular response to vitamin B6cellular response to vitamin B2cellular response to vitamin B1cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholinecellular response to thiabendazole
P279
Transformation related protein 53Uridine monophosphate synthetaseRenin 1 structuralAdiponectin, C1Q and collagen domain containingPotassium voltage-gated channel, subfamily Q, member 1Toll-like receptor 3Prion proteinQuinoid dihydropteridine reductaseChemokine (C-C motif) ligand 4Checkpoint kinase 2Integrin beta 3Potassium voltage-gated channel, Isk-related subfamily, gene 2Solute carrier family 18 (vesicular monoamine), member 2Interleukin 1 betaUridine monophosphate synthetaseMajor prion proteinDopa decarboxylaseRAP1B, member of RAS oncogene familyCRK like proto-oncogene, adaptor proteinPhosphodiesterase 2APotassium voltage-gated channel subfamily C member 1B-Raf proto-oncogene, serine/threonine kinaseCD69 moleculeCorticotropin releasing hormone binding proteinGrowth arrest specific 6Protein phosphatase 1 regulatory subunit 12ATransferrin receptorNitric oxide synthase 2Protein kinase AMP-activated catalytic subunit alpha 2Heat shock transcription factor 1Absent in melanoma 2Heat shock protein family A (Hsp70) member 5Phosphodiesterase 4AElongation factor Tu GTP binding domain containing 2Protein phosphatase 3 catalytic subunit betaMyocyte enhancer factor 2CMetallothionein 3SRY-box transcription factor 10Nuclear factor, erythroid 2 like 2Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
P682
Q14819899-B10EA0AC-DABC-4BDB-98CC-F19C6D0226D1Q14819900-34FC3D10-0BB2-4A2B-B545-30BF21DE34B8Q14862213-1E008F49-2DDD-4D96-8C77-32D27D409484Q14864816-24B52A0E-E3FE-4B1F-9DA5-18F8079C75A6Q14864817-7555C409-85B6-46E5-9ABF-587F4AC10584Q14865235-BE10E7F0-8F12-4256-8728-83142D965FEEQ14897692-AB11D2BB-038C-413E-BDAB-C97D3BA4307CQ14901444-ABA61FA8-2D59-47C2-B8BD-60CD99256C63Q14905236-FC56B61F-AA4C-430A-B14F-F741DEFC8259Q14907731-6E27A5BD-5411-4CEE-97D5-6F1467C3B61FQ21095106-6BB00C9C-F628-4F7B-9E79-DF5E2E364EB1Q21095318-A0F2C9EA-6A22-4A8C-A026-967AC80557AFQ21095320-B7193B6B-E3B4-461F-A169-0C4058D69CE7Q21100531-12F73CE1-470F-4B24-AD04-70F3B6CC84C1Q21106739-127D73D5-CD4B-4944-A429-6E7A600B3C02Q21107379-B55FC382-4560-423A-B480-AA254EFE6AB5Q21109352-8CAB1D9E-502B-4B3E-A01A-2E024842A310Q21111194-40AF7E7A-6A89-4C26-9B8E-7947FE601CF8Q21111676-366C17FD-568B-42ED-84CF-8ACEA5E5EB2DQ21111901-31DC8F2D-C077-4A45-A2F2-859C93176E93Q21114205-36D0DA17-E68D-4F81-B7C5-65049395B021Q21115714-CC9F0446-B8E8-49AB-81FA-D1DA3CECD38CQ21116464-BB70D643-7817-46B4-9BEB-73BED6151655Q21118595-96A3C28C-D8E3-4187-BB45-8FEA14B48B9EQ21123557-8BFE5077-B4FD-446C-807C-6F48A4363A5BQ21173728-1AC26F7B-B66F-464A-AAB5-85CA33B0E969Q21435787-74BBFAA1-C66B-4211-9EEF-0501301FDE86Q21469631-DBFB084F-7945-4C74-9A26-39E45E77C5B8Q21496792-8DDC21B7-4DF8-403A-B488-75D565710EFEQ22272330-746228B3-4CD3-432A-9394-47BD01AD6B73Q22272333-00136443-8482-4468-A493-3E25CDB9A9BBQ22273166-2DE46E9C-AEE1-4ECA-9F6C-E97A3BD0DC7AQ22273169-BAE5E613-471D-4604-9D54-277481E3F7A8Q22273180-B8FF4B9E-C97B-40F8-831C-FD6AE456F651Q22273181-C7E743BE-F7A2-472F-8A94-8CD36B4B0A61Q22273186-835EE05E-2305-4CBB-A77E-3C9E2DEC9B01Q22273188-7BFC5F3C-8541-4B5C-9642-3F83769A52C7Q22273191-DE31F74B-F6AA-4873-AD47-83929F812F25Q22273227-1EA5BE8A-EB7C-4FC8-8CA0-001D11ECA33AQ22273233-AFCDDB14-941E-416D-924A-69F7FC95A413
P279
Q14818136-FB9FAE3F-3923-4FAD-944C-7417C1F3189AQ14859877-379CFD40-7EF9-4A20-AB93-17762BBB3B89Q14861557-9689910D-3C25-4C54-A751-ECDBF30F2F54Q14864062-5C8BA95B-8481-443C-AA71-0B4F457E8E10Q14865158-84AE7C84-4663-4DFE-8FD7-71706CADD526Q14866248-7DC76250-434A-4D5B-946F-86A2B0565B7FQ14881308-41F33E20-5ED6-4BF6-BF2F-4AB22950BD2AQ14885017-C5C32E48-EBBF-4695-BAB9-83C0D50FD4DDQ14907553-1E1B85E2-4BB4-469B-8451-62535296E205Q14912285-57A0B868-9D27-43F9-B24F-EB0341E5A9C9Q14913644-0E95A6E9-3F4A-4A16-8588-23EBAAC26701Q14914051-DA1D6FEE-8904-48FF-8DF6-EDF1865D833BQ14916237-BB59F812-B621-4600-9E48-B9CF97639087Q14916414-13445AAA-6E6E-44E6-B20F-A53F8479041AQ1499999-B19DC859-AA1C-49F6-BBA8-E0B13F9D6AF0Q21096129-AC5C9C48-13C7-455D-BB4F-0E6F730D6BB4Q21097237-5A7FC284-CAD5-405E-8C84-CB16A9728743Q21103244-08A886C1-1E26-4DCC-A8A4-5823DCDC93B0Q21104798-94E0B6F4-E2D0-4BCB-B009-7C4927DD99C8Q21105011-16C7653D-0264-4A25-804A-3D31163959C5Q21105011-CD7A2295-4279-4E4E-BDD3-042A12181C78Q21107877-245432EB-9E24-4D75-B46D-0B9DD125B533Q21109218-80692869-F076-459E-9DA5-71B5832A5BACQ21109696-E1CB76AF-ABD5-48E4-A651-60313C02C3B4Q21110775-73046A89-65BD-40F5-A8C4-776E2D5E4FA3Q21110911-A41E5973-C62F-47D0-A9C0-911269B69B07Q21112088-FB4E4D7A-2F0D-435C-B2EC-447CDFF66F63Q21112583-D36F38E0-C55E-4137-988E-6978F922804FQ21114547-3A728ADC-0E39-4761-9FC5-2B58583F6A85Q21115165-5857FE37-52EA-4DC4-844D-BF8C34F732C3Q21116003-3FDEABFC-1D1B-45CE-BCEC-FBC3528F94C9Q21116442-A3EBF83A-2D3D-477D-8C0A-C9A253D8F6ACQ21116494-F252F8A6-5255-45A3-A1DF-647CD9E279D2Q21117805-F0F4F64C-9439-4712-A4D2-2FC87B5B7C2CQ21118377-D4178FF4-45F3-4378-A747-77C87137CA19Q21118452-FC84518B-88E7-43E6-A29F-4FD969536C73Q21118717-E860537D-E5B1-4F31-A5DB-CB0822964E07Q21118811-C5791BA5-855E-4E7E-925A-EB8F08DC3365Q21118857-7EE120CD-2AD9-4704-9D17-98AE8650567CQ21119871-9B64E5D5-C083-4BD0-84FE-928E0E526FAE
P682
description
Any process that results in a ...... , treatment or prevention of a
@en
biologisch proces
@nl
name
cellular response to drug
@en
ĉela respondo al medikamento
@eo
type
label
cellular response to drug
@en
ĉela respondo al medikamento
@eo
altLabel
GO:0035690
@en
prefLabel
cellular response to drug
@en
ĉela respondo al medikamento
@eo
P2888
P686
GO:0035690